Specific features of a metabolomic profile in preeclampsia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To search for markers for predicting preeclampsia on the basis of metabolomic analysis using mass spectrometry and bioinformatics. Subjects and methods. The investigation included two groups of pregnant women: a study group of 13 pregnant women with preeclampsia and a comparison group of 21 pregnant women with physiological pregnancy. Serum metabolite prof iles were obtained using liquid chromatography- mass spectrometry. Results. The investigators identified 22 amino acids with statistically significantly different concentrations: 3-methylhistidine, alanine, anserine, arginine, aspartate, carnosine, cystine, ethanolamine, glutamate, glutamine, glycine, histidine, homocitrulline, lysine, methionine, norvaline, O-phosphorylethanolamine, ornithine, phenylalanine, serine, threonine, and tyrosine. There was a moderate correlation with 3 amino acids: carnosine (KK = 0.526, p <0.001), arginine (KK = 0.437;p <0.001), ethanolamine (KK = 0.403;p = 0.003). In addition, there was a correlation of carnosine with hypertension (KK = 0.375; p = 0.038), proteinuria (KK = 0.543; p <0.001); arginine and ethanolamine also correlated with the level of high blood pressure (KK = 0.462; p = 0.009, and KK = 0.428; p = 0.002) and proteinuria (KK = 0.428; p = 0.002. and KK = 0.431, p = 0.002). Analysis of the ROC curves showed that carnosine, arginine, and ethanolamine were potentially sensitive and specific biomarkers for the diagnosis and prediction of preeclampsia (the area under the curve was 0.848, 0.789, and 0.767, respectively). Conclusion. The results of the investigation have shown that determination of the metabolic profile is of great clinical significance for predicting preeclampsia.

Full Text

Restricted Access

About the authors

N. E Kan

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: kan-med@mail.ru

N. A Lomova

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: natasha-lomova@yandex.ru

E. Yu Amiraslanov

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: e_amiraslanov@oparina4.ru

V. V Chagovets

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: vvchagovets@gmail.com

V. L Tyutyunnik

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tioutiounnik@mail.ru

Z. V Khachatryan

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: z.v.khachatryan@gmail.com

N. L Starodubtseva

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: n_starodubtseva@oparina4.ru

N. A Kitsilovskaya

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: kitsilovskyana@gmail.com

V. E Frankevich

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: v_frankevich@oparina4.ru

References

  1. Сидорова И.С., Никитина Н.А., Унанян А.Л. Преэклампсия и снижение материнской смертности в России. Акушерство и гинекология. 2018; 1: 107-12. https://dx.doi.org/10.18565/ aig.2018.1.107-112
  2. Nicholson J.K., Lindon J.C. Metabolomics. Nature. 2008; 455(7216):1054-6. doi: 10.1038/4551054a.
  3. Spratlin J.L., Serkova N.J., Eckhardt S.G. Clinical Applications of Metabolomics in Oncology: A Review. Clin Cancer Res. 2009; 15: 431-440. doi: 10.1158/1078-0432.CCR-08-1059.
  4. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002; 1: 153-161. doi: 10.1038/nrd728
  5. Zeisel S.H., Waterland R.A., Ordovds J.M., Muoio D.M., Jia W., Fodor A. Highlights of the 2012 Research Workshop: Using Nutrigenomics and Metabolomics in Clinical Nutrition Research. J Parent Ent Nutr. 2013; 37: 190200. doi: 10.1177/0148607112462401
  6. Madsen R., Lundstedt T., Trygg J. Chemometrics in metabolomics-A review in human disease diagnosis. Anal Chim Act. 2010; 659: 23-33. doi: 10.1016/ j.aca.2009.11.042.
  7. Fanos V., Antonucci R., Barberini L., Atzori L. Urinary metablomics in the newborn and infants. Adv Clin Chem 2012; 58: 193-223. doi: 10.1016/b978-0-12-394383-5.00013-8
  8. Fanos V., Antonucci R., Barberini L., Noto A., Atzori L. Clinical application of metabolism in neonatology. J Matern Fetal Neonatal Med. 2012; 1: 104-109.
  9. Fanos V., Van den Anker J., Noto A., Mussap M., Atzori L. Metabolomics in neonatology: fact or fiction? Semin Fetal Neonatal Med. 2013; 18: 3-12. doi: 10.1016/j.siny.2012.10.014.
  10. Benton S.J., Ly C., Vukovic S., Bainbridge S.A. Andree Gruslin award lecture: Metabolomics as an important modality to better understand preeclampsia. Placenta. 2017; 60 Supp l 1:S32-S40. doi: 10.1016/j.placenta.2016.11.006.
  11. Kenny L.C., Broadhurst D., Brown M., Dunn W.B., Redman C.W., Kell D.B., et al. Detection and Identification of Novel Metabolomic Biomarkers in Preeclampsia. Repr Scie. 2008; 15: 591-597. doi: 10.1177/1933719108316908.
  12. Kenny L.C., Broadhurst D.I., Dunn W., Brown M., North R.A., McCowan L., et al. Screening for Pregnancy Endpoints Consortium. Robust early pregnancy prediction of later preeclampsia using metabolomics biomarkers. Hyperension. 2010; 56: 741-749. doi: 10.1161/HYPERTENSIONAHA.110.157297.
  13. Odibo A.O., Goetzinger K.R., Odibo L., Cahill A.G., Macones G.A., Nelson D.M., et al. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn. 2011; 31: 990-4. doi: 10.1002/pd.2822.
  14. Bahado-Singh R.O., Akolekar R., Mandal R., Dong E., Xia J., Kruger M., et al. Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012; 25(10): 1840-7. doi: 10.3109/14767058.2012.680254.
  15. Bahado-Singh R.O., Syngelaki A., Akolekar R., Mandal R., Bjondahl T.C., Han B., et al. Validation of metabolomic models for prediction of early-onset preeclampsia. Am J Obstet Gynecol. 2015; 213(4): 530.e1-530.e10. doi: 10.1016/j.ajog.2015.06.044.
  16. Austdal M., Tanger as L.H., Skrastad R.B., Salve sen K., Austgulen R., Iversen A.C., et al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int J Mol Sci. 2015; 16(9): 21520-38. doi: 10.3390/ ijms160921520.
  17. Mukherjee R., Ray C.D., Ray S., Dasgupta S., Chaudhury K. Altered metabolic profile in early and late onset preeclampsia: an FTIR spectroscopic study. Pregn Hypert. 2014; 4(1): 70-80. doi: 10.1016/j.preghy.2013.11.005.
  18. Vadillo-Ortega F., Espino S., Avila-Vergara M.A., Ibarra I., Ahued R., Godines M. et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 2011; 342: d2901. doi: 10.1136/bmj.d2901.
  19. Zhang X., Song L., Cheng X., Yang Y., Luan B., Jia L., et al. Carnosine pretreatment protects against hypoxia-ischemia brain damage in the neonatal rat model. Eur J Pharmacol. 2011; 667: 202-207. doi: 10.1016/j.ejphar.2011.06.003.
  20. Cheng J., Wang F., Yu D.F, Wu P.F., Chen J.G. The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/ mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons. Eur J Pharmacol. 2011; 650(1): 184-94. doi: 10.1016/j.ejphar.2010.09.033.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies